Testing your INR weekly has been proven to reduce major bleeding and stroke for patients on Coumadin® (warfarin).

Improving control provides an added safety margin to warfarin shown to reduce dangerous side effects by over 50% *
_{* Ann Intern Med. 2000}

Take these 3 steps to improve your safety.

Identify if you are a candidate for home INR testing.

If you are taking Coumadin and your answer to any of these questions is YES, you are a good candidate for INR self-testing.

Do you take many other medications with your Coumadin?
Would you like to be in your INR range more often?
Are you concerned where your INR is between lab visits?
Can you perform a finger-stick or do you have a support person who could help?

Find out if insurance will cover home INR testing.

Most Private Insurance plans cover home INR testing for patients taking Coumadin® (warfarin).

Medicare patients with a mechanical heart valve are covered for weekly testing at home (You must be taking Coumadin® / warfarin for 90 days or more to be automatically eligible)

Have a question? Call 1-800-298-4515 and speak to our staff.

It only takes a few minutes to Get Started.

Fill out this information request form and we will do the rest! QAS is committed to keeping the process easy for you.

We will handle the prescription forms with your doctor and the insurance process with your health plan.

Our coverage team will keep you informed throughout the process regarding your eligibility and status of obtaining your INR monitor.

Testing your INR weekly has been proven to reduce major bleeding and stroke for patients on Coumadin® (warfarin). Improving control provides an added safety margin to warfarin shown to reduce dangerous side effects by over 50% * * Ann Intern Med. 2000

Take these 3 steps to improve your safety.

Identify if you are a candidate for home INR testing.

Find out if insurance will cover home INR testing.

It only takes a few minutes to Get Started.

Please fill out this form for more information:

Testing your INR weekly has been proven to reduce major bleeding and stroke for patients on Coumadin® (warfarin).

Improving control provides an added safety margin to warfarin shown to reduce dangerous side effects by over 50% *
_{* Ann Intern Med. 2000}